Pfizer Case - Pfizer Case Study Pfizer is a health service...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Pfizer Case Study Pfizer is a health service provider who claims they are “the leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas” and has recently acquired King Pharmaceuticals, a leading painkiller provider. Their motto is “We will become the world’s most valued company to patients, customers, colleagues, investors, business partners and communities where we work and live.” Recently, the company has recalled around 100,000 bottles of the painkiller Embeda from US wholesalers and retailers because testing showed it didn’t “meet stability standards”. The medicine contains an additive known as Naltrexone which is designed to prevent users from becoming dependent on the drug. The recall was issued after a large batch of pills had been discovered whose Naltrexone had been degraded to an unacceptable level. This is not the first problem the drug has had with its researching. It has been recalled many times last year due to problems with dissolution upon ingestion among other issues concerning formula. What would Friedman say? How would someone supporting his views approach the issue?
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 08/29/2011 for the course BUS 101 taught by Professor Rollins during the Spring '08 term at Miami University.

Page1 / 4

Pfizer Case - Pfizer Case Study Pfizer is a health service...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online